Health Canada is advising patients who use MiniCap Extended Life Peritoneal Dialysis Transfer Sets, manufactured by Baxter Corporation, that direct contact between the sets and certain cleaning products, including hand sanitizers and solvents, may damage the sets. Damaged sets could leak or crack, which may cause microbial contamination leading to the development of peritonitis in some cases. Peritonitis is the inflammation of the lining of the abdomen, caused by infection, which can be serious if not promptly treated. Symptoms include nausea, vomiting, and abdominal pain or tenderness. If you experience symptoms of peritonitis, seek medical attention immediately. Damaged sets may also lead to a delay in therapy as you seek medical assistance to change your transfer set. A transfer set is tubing that connects the catheter in the body to the bag of dialysis solution in the treatment of renal (kidney) failure. Using a transfer set helps protect the catheter from damage that may be caused by frequent clamping during dialysis exchange procedures. These transfer sets are installed by trained health care providers for use in health care and home settings. Peritoneal dialysis patients receiving dialysis at home need to open and close the transfer set several times a day to connect to fresh dialysis solution and drain existing solution from their abdomen. Baxter Corporation has informed Health Canada that, to date, it has received 13 reports internationally of peritonitis possibly related to this issue, including one Canadian case. The company has also informed Health Canada that it has notified all affected customers (health care facilities), and will update the product Instructions for Use to warn that use of the following products should be avoided on the transfer sets: hand sanitizers and cleaning products that contain hydrogen peroxide, bleach, alcohol or antiseptic agents; and solvents intended to remove adhesive residue, such as those containing acetone, toluene, xylene, or cyclohexanone The Department is monitoring the effectiveness of this corrective action and will inform Canadians if any new health risks are identified.